147
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

A validated high performance liquid chromatography – diode array detector method for the quantification of mitomycin C in plasma, peritoneal fluid and urine

, , , , , ORCID Icon, & show all
Pages 839-848 | Received 03 Jul 2018, Accepted 08 Sep 2018, Published online: 30 Nov 2018

References

  • Begleiter, A. Clinical Applications of Quinone-Containing Alkylating Agents. Front Biosci. 2000, 5, E153–E171. DOI:10.2741/A483
  • Bachur, N. R.; Gordon, S. L.; Gee, M. V.; Kon, H. NADPH Cytochrome P-450 Reductase Activation of Quinone Anticancer Agents to Free Radicals. Proc. Natl. Acad. Sci. U.S.A. 1979, 76, 954–954. DOI:10.1073/pnas.76.2.954
  • Verwaal, V. J.; Bruin, S.; Boot, H.; van Slooten, G.; van Tinteren, H. 8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer. Ann. Surg. Oncol. 2008, 15, 2426–2432. DOI:10.1245/s10434-008-9966-2
  • Van der Speeten, K.; Stuart, O. A.; Chang, D.; Mahteme, H.; Sugarbaker, P. H. Changes Induced by Surgical and Clinical Factors in the Pharmacology of Intraperitoneal Mitomycin C in 145 Patients with Peritoneal Carcinomatosis. Cancer Chemother. Pharmacol. 2011, 68, 147–156. DOI:10.1007/s00280-010-1460-4
  • Jacquet, P.; Averbach, A.; Stephens, A. D.; Stuart, O. A.; Chang, D.; Sugarbaker, P. H. Heated Intraoperative Intraperitoneal Mitomycin C and Early Postoperative Intraperitoneal 5-Fluorouracil: Pharmacokinetic Studies. Oncology. 1998, 55, 130–138. DOI:10.1159/000011847
  • Fujita, T.; Tamura, T.; Yamada, H.; Yamamoto, A.; Muranishi, S. Pharmacokinetics of Mitomycin C (MMC) after Intraperitoneal Administration of MMC-Gelatin Gel and Its Anti-tumor Effects Against Sarcoma-180 Bearing Mice. J. Drug Targeting 1997, 4, 289–296. DOI:10.3109/10611869708995844
  • Mohamed, F.; Cecil, T.; Moran, B.; Sugarbaker, P. A New Standard of Care for the Management of Peritoneal Surface Malignancy. Curr. Oncol. (Toronto, Ont.) 2011, 18, e84–e96.
  • Levine, E. A.; Stewart, J. H. T.; Shen, P.; Russell, G. B.; Loggie, B. L.; Votanopoulos, K. I. Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy: Experience with 1,000 Patients. J. Am. Coll. Surg. 2014, 218, 573–585. DOI:10.1016/j.jamcollsurg.2013.12.013
  • Gonzalez-Moreno, S.; Gonzalez-Bayon, L.; Ortega-Perez, G. Hyperthermic Intraperitoneal Chemotherapy: Methodology and Safety Considerations. Surg. Oncol. Clin. North Am. 2012, 21, 543–557. DOI:10.1016/j.soc.2012.07.001
  • B'Hymer, C.; Connor, T.; Stinson, D.; Pretty, J. Validation of an HPLC-MS/MS and Wipe Procedure for Mitomycin C Contamination. J. Chromatogr. Sci. 2015, 53, 619–624. DOI:10.1093/chromsci/bmu095
  • Kinast, R. M.; Akula, K. K.; DeBarber, A. E.; Barker, G. T.; Gardiner, S. K.; Whitson, E.; Mansberger, S. L. The Degradation of Mitomycin C Under Various Storage Methods. J. Glaucoma. 2016, 25, 477–481. DOI:10.1097/IJG.0000000000000287
  • Dalton, J. T.; Geuns, E. R.; Au, J. L. High-Performance Liquid Chromatographic Determination of Mitomycin C in Rat and Human Plasma and Urine. J. Chromatogr. 1989, 495, 330–337. DOI:10.1016/S0378-4347(00)82641-9
  • Song, D.; Au, J. L. Direct Injection Isocratic High-Performance Liquid Chromatographic Analysis of Mitomycin C in Plasma. J. Chromatogr. B Biomed. Appl. 1996, 676, 165–168. DOI:10.1016/0378-4347(95)00406-8
  • Joseph, G.; Biederbick, W.; Woschee, U.; Theisohn, M.; Klaus, W. Sensitive and Convenient High-Performance Liquid Chromatographic Method for the Determination of Mitomycin C in Human Plasma. J. Chromatogr. B Biomed. Sci. Appl. 1997, 698 (1–2), 261–267. DOI:10.1016/S0378-4347(97)00291-0
  • Paroni, R.; Arcelloni, C.; De Vecchi, E.; Fermo, I.; Mauri, D.; Colombo, R. Plasma Mitomycin C Concentrations Determined by HPLC Coupled to Solid-Phase Extraction. Clin. Chem. 1997, 43, 615–618.
  • Schmid, K.; Boettcher, M. I.; Pelz, J. O.; Meyer, T.; Korinth, G.; Angerer, J.; Drexler, H. Investigations on Safety of Hyperthermic Intraoperative Intraperitoneal Chemotherapy (HIPEC) with Mitomycin C. Eur. J. Surg. Oncol. 2006, 32, 1222–1225. DOI:10.1016/j.ejso.2006.05.011
  • Eksborg, S.; Ehrsson, H.; Lindfors, A., Liquid Chromatographic Determination of Mitomycin C in Human Plasma and urine. J. Chromatogr. 1983, 274, 263–270. DOI:10.1016/S0378-4347(00)84429-1
  • Vibha Gupta, A. D. K. J.; Gill, N. S.; Gupta, K. Development and Validation of HPLC Method – A Review. Int. Res. J. Pharm. Appl. Sci. 2012, 2, 17–25.
  • Morrison, J. G.; White, P.; McDougall, S.; Firth, J. W.; Woolfrey, S. G.; Graham, M. A.; Greenslade, D., Validation of a Highly Sensitive ICP-MS Method for the Determination of Platinum in Biofluids: Application to Clinical Pharmacokinetic Studies with Oxaliplatin. J. Pharm. Biomed. Anal. 2000, 24, 1–10. DOI:10.1016/S0731-7085(00)00377-0
  • Witkamp, A., Dose Finding Study of Hyperthermic Intraperitoneal Chemotherapy with Mitomycin C in Patients with Carcinosis of Colorectal Origin. Eur. J. Surg. Oncol. 1998, 24, 18.
  • den Hartigh, J.; Van Oort, W. J., High Performance Liquid Chromatographic Determination of the Antitumor Agent Mitomcyin C in Human Blood Plasma. Anal. Chim. Acta. 1981, 127, 47–53. DOI:10.1016/S0003-2670(01)83960-X
  • Sugarbaker, P. H.; Stuart, O. A.; Carmignani, C. P., Pharmacokinetic Changes Induced by the Volume of Chemotherapy Solution in Patients Treated with Hyperthermic Intraperitoneal Mitomycin C. Cancer Chem. Pharmacol. 2006, 57, 703–708. DOI:10.1007/s00280-005-0074-8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.